Polypharmacy is a cost and safety problem that is solvable. The right technology platform can reduce it by identifying risky regimens, route specific “stop/switch/consolidate” opportunities to clinicians, and track whether changes stick through refill and adherence patterns.
The DEA’s anticipated extension of telehealth prescribing flexibility once again averts an immediate disruption in care, but it leaves providers and patients in the same cycle of uncertainty that has persisted for years.
Discover the top AI-powered EAP providers for 2026. Compare platforms like Kyan Health and Spring Health on triage speed, global reach, and clinical quality to transform workforce wellbeing.
Although the healthcare industry has a long way to go before PGx testing for DPYD and other genes becomes widespread, it's encouraging that regulatory bodies and professional organizations are making recommendations and raising awareness among healthcare providers.
By integrating industry standards into e-prescribing software, prescribing organizations can reduce errors to improve patient outcomes and lessen the burden of medication-related errors on healthcare systems. Here’s a look at the new National Council for Prescription Drug Programs (NCPDP) Sig Standard aimed at improving prescription accuracy.
Engaging in data sharing, observational cohort research, and deeper analysis of available data to yield further insights can drive improved results for patients, making label and cohort extension faster and more robust.
As the pandemic rages on, the other major public health crisis in recent history has not ebbed. The opioid epidemic is worsening, but providers have kept their eye on the ball and are continuing their efforts to treat opioid use disorder and curb unnecessary prescriptions. Here is a snapshot of those efforts.
We'll explore why the next era of payer performance will depend on building a trusted data foundation that connects people, providers, and relationships across the enterprise.